Overview

The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus

Status:
Active, not recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

This study evaluates the addition of an alginate based solution to twice daily proton pump inhibitor therapy (PPI) in patients undergoing ablative therapy for dysplastic Barrett's esophagus. The investigators hypothesize that the addition of this medication will help to achieve complete remission of Barrett's over a shorter period of time.

Phase:

Phase 2

Details

Lead Sponsor:

Medical University of South Carolina

Collaborator:

MUSC GI and research staff

Treatments:

Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
Alginic acid
Proton Pump Inhibitors